Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2026-01-02 @ 3:18 PM
Study NCT ID:
NCT07142551
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-12-17
First Post:
2025-08-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
J2564
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |